UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Alternative Approach to BIPSS in the Differential Diagnosis of ACTH-Dependent Cushing Syndrome

The journal of clinical endocrinology and metabolism, 2024-05, Vol.109 (6), p.e1460-e1461

2024

Volltextzugriff (PDF)

The genetic background of acromegaly

Pituitary, 2017-02, Vol.20 (1), p.10-21

2017

Volltextzugriff (PDF)

Hypopituitarism

The Lancet (British edition), 2024-06, Vol.403 (10444), p.2632-2648

2024

Volltextzugriff (PDF)

The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease

The journal of clinical endocrinology and metabolism, 2015-07, Vol.100 (7), p.E997-E1004

2015

Volltextzugriff (PDF)

Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

European journal of endocrinology, 2007-01, Vol.156 (1), p.65-74

2007

Volltextzugriff (PDF)

Prolactinomas

La Presse médicale (1983), 2021-12, Vol.50 (4), p.104080-104080, Article 104080

2021

Volltextzugriff (PDF)

Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

European journal of endocrinology, 2008-03, Vol.158 (3), p.295-303

2008

Volltextzugriff (PDF)

Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53

Neuroendocrinology, 2011-07, Vol.94 (1), p.39-48

2011

Volltextzugriff (PDF)

Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor

European journal of endocrinology, 2018-01, Vol.178 (1), p.57-63

2018

Volltextzugriff (PDF)

GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in Brazil

Endocrine, 2021-10, Vol.74 (1), p.146-154

2021

Volltextzugriff (PDF)

Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome

Clinical endocrinology (Oxford), 2014-11, Vol.81 (5), p.657-664

2014

Volltextzugriff (PDF)

Acromegaly Has a Negative Influence on Trabecular Bone, But Not on Cortical Bone, as Assessed by High-Resolution Peripheral Quantitative Computed Tomography

The journal of clinical endocrinology and metabolism, 2013-04, Vol.98 (4), p.1734-1741

2013

Volltextzugriff (PDF)

Growth hormone receptor exon 3 isoforms may have no importance in the clinical setting of multiethnic Brazilian acromegaly patients

Pituitary, 2016-08, Vol.19 (4), p.375-380

2016

Volltextzugriff (PDF)

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

European journal of endocrinology, 2020-06, Vol.182 (6), p.583

2020

Volltextzugriff (PDF)

Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study

Clinical endocrinology (Oxford), 2009-05, Vol.70 (5), p.757-768

2009

Volltextzugriff (PDF)

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

The lancet. Diabetes & endocrinology, 2014-11, Vol.2 (11), p.875-884

2014

Volltextzugriff (PDF)

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

The journal of clinical endocrinology and metabolism, 2008-06, Vol.93 (6), p.2390-2401

2008

Volltextzugriff (PDF)

Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control

Hormones (Athens, Greece), 2017-01, Vol.16 (1), p.84-91

2017

Volltextzugriff (PDF)

A subcutaneous octreotide hydrogel implant for the treatment of acromegaly

Endocrine practice, 2012-11, Vol.18 (6), p.870-881

2012

Volltextzugriff (PDF)

Growth of an aggressive tumor during pregnancy in an acromegalic patient

Endocrine Journal, 2012, Vol.59(4), pp.313-319

2012

Volltextzugriff (PDF)

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

BMC endocrine disorders, 2016-04, Vol.16 (16), p.16-16, Article 16

2016

Volltextzugriff (PDF)

Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas

PloS one, 2015-02, Vol.10 (2), p.e0117107-e0117107

2015

Volltextzugriff (PDF)

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

Endocrine, 2016-07, Vol.53 (1), p.210-219

2016

Volltextzugriff (PDF)

Body self-image disturbances in women with prolactinoma

Revista brasileira de psiquiatria, 2020-01, Vol.42 (1), p.33-39

2020

Volltextzugriff (PDF)

Efficacy of medical treatment in Cushing's disease: a systematic review

Clinical endocrinology (Oxford), 2014-01, Vol.80 (1), p.1-12

2014

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(95)
Buchkapitel
(1)

Sprache

Englisch
(92)
Portugiesisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alternative Approach to BIPSS in the Differential Diagnosis of ACTH-Dependent Cushing Syndrome

The genetic background of acromegaly

Hypopituitarism

The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease

Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas

Prolactinomas

Quantitative analysis of somatostatin receptor subtypes (1-5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53

Somatic USP8 mutations are frequent events in corticotroph tumor progression causing Nelson's tumor

GH and IGF-I levels and tumor shrinkage in response to first generation somatostatin receptor ligands in acromegaly: a comparative study between two reference centers for pituitary diseases in Brazil

Rotation thromboelastometry and the hypercoagulable state in Cushing's syndrome

Acromegaly Has a Negative Influence on Trabecular Bone, But Not on Cortical Bone, as Assessed by High-Resolution Peripheral Quantitative Computed Tomography

Growth hormone receptor exon 3 isoforms may have no importance in the clinical setting of multiethnic Brazilian acromegaly patients

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study

Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

Somatotropinomas inadequately controlled with octreotide may over-respond to pasireotide: the importance of dose adjustment to achieve long-term biochemical control

A subcutaneous octreotide hydrogel implant for the treatment of acromegaly

Growth of an aggressive tumor during pregnancy in an acromegalic patient

Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study

Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas

Effect of pasireotide on glucose- and growth hormone-related biomarkers in patients with inadequately controlled acromegaly

Body self-image disturbances in women with prolactinoma

Efficacy of medical treatment in Cushing's disease: a systematic review

Aktive Filter

Suchergebnisse filtern